AngioGenex
About:
AngioGenex is a biopharmaceutical company dedicated to the development of treatment for vascular diseases.
Website: http://www.angiogenex.com/
Top Investors: Sand Hill Angels, Atypical BioVentures
Description:
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Total Funding Amount:
$875000
Headquarters Location:
New York, New York, United States
Founded Date:
1999-01-01
Contact Email:
info(AT)angiogenex.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2005-01-01
IPO Status:
Public
Industries:
© 2025 bioDAO.ai